Pancreatic tuberculosis mimicking pancreatic cancer in immunocompetent patients: Case series and diagnostic pathways
Abstract
We retrospectively reviewed the clinical presentations, diagnostic evaluations, imaging findings, and treatment outcomes of 3 patients diagnosed with pancreatic tuberculosis. All 3 patients presented with nonspecific symptoms such as epigastric pain and weight loss. Imaging showed pancreatic masses suggestive of pancreatic cancer. EUS with FNA and subsequent histopathology confirmed tuberculosis through the presence of granulomas with caseous necrosis. All patients received anti-tuberculosis therapy, leading to favorable outcomes, including pain resolution and normalization of follow-up imaging.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.